Dropprint Genomics
Curated by SignalDeveloper of genomics data sets for drug discovery
Overview
Dropprint Genomics is developing single-cell technology to profile gene data sets for the development of drugs for immune-based diseases. The company uses its single-cell technology and machine learning models to identify gene data sets and characterize the data from large populations for understanding the immune system.
Key facts
- Founded
- 2019
- Headquarters
- San Francisco, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 3 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view